Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Repeated mild traumatic brain injury induces astrocytic dysfunction, metabolic imbalance and disrupts lipid homeostasis.This leads to the aberrant release of specific lipid species (diacylglycerol) which activate protein kinase C signalling in neurons and drive delayed neurotoxic cascades.
Repeated mild traumatic brain injury induces astrocytic dysfunction, metabolic imbalance and disrupts lipid homeostasis.This leads to the aberrant release of specific lipid species (diacylglycerol) which activate protein kinase C signalling in neurons and drive delayed neurotoxic cascades.

Traumatic brain injury (TBI) affects approximately 70 million people worldwide every year and remains a major cause of death and long-term neurological disability. Despite this enormous global burden, there remains an urgent need for treatments that can prevent the secondary cellular damage that continues after the initial injury.

A new paper by the Salman Group has now developed a human “TBI-in-a-dish” model that reveals how repeated mild brain injury can leave astrocytes persistently altered, triggering delayed damage to neighbouring neurons.

Published in Cell Death & Disease, the study was spearheaded by Luise Schlotterose and recreates repeated mechanical injury in human astrocytes, allowing researchers to follow the cellular consequences of trauma beyond the initial impact.

The team found that repeated injury profoundly disrupted astrocyte homeostasis, causing lipid accumulation, metabolic dysfunction and a biphasic response in cell volume, culminating in delayed swelling associated with changes in the water channel aquaporin-4 (AQP4). Importantly, these persistent changes suggest that astrocytes retain a form of “cellular memory” of trauma, with the consequences of injury continuing to evolve long after the initial mechanical insult.

Crucially, the study uncovered an unexpected mechanism connecting injured astrocytes to subsequent neuronal death. Rather than a classical inflammatory response driven by cytokines, repeated injury altered astrocyte lipid signalling, with specific bioactive diacylglycerols activating PKCδ signalling in neurons. Blocking this pathway reduced neuronal toxicity, identifying a potentially druggable mechanism linking traumatic injury to delayed neurodegeneration.

Beyond revealing this pathway, the “TBI-in-a-dish” platform provides a controllable human experimental system in which candidate mechanisms can now be targeted directly. Its scalability also opens the door to screening larger libraries of compounds to identify drugs capable of preventing or reversing the secondary damage that follows TBI, providing a potential bridge between mechanistic discovery and therapeutic development.

The research was supported by the Medical Research Council, British Heart Foundation, UK Dementia Research Institute and BHF Oxford Centre of Research Excellence, with additional fellowship support for Dr Schlotterose from the Royal Society.

Read the paper: From injury to degeneration: delayed lipid-mediated neurotoxicity in a human astrocyte traumatic brain injury in-a-dish model, published in Cell Death & Disease.